Excess of Solid Cancers After Prasugrel: The Food and Drug Administration Outlook.
Publication
, Journal Article
Ohman, EM; Roe, MT
Published in: Am J Ther
2016
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Am J Ther
DOI
EISSN
1536-3686
Publication Date
2016
Volume
23
Issue
1
Start / End Page
e243 / e244
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Prasugrel Hydrochloride
- Platelet Aggregation Inhibitors
- Neoplasms
- Humans
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
Citation
APA
Chicago
ICMJE
MLA
NLM
Ohman, E. M., & Roe, M. T. (2016). Excess of Solid Cancers After Prasugrel: The Food and Drug Administration Outlook. Am J Ther, 23(1), e243–e244. https://doi.org/10.1097/MJT.0b013e31824ea5f9
Ohman, E Magnus, and Matthew T. Roe. “Excess of Solid Cancers After Prasugrel: The Food and Drug Administration Outlook.” Am J Ther 23, no. 1 (2016): e243–44. https://doi.org/10.1097/MJT.0b013e31824ea5f9.
Ohman EM, Roe MT. Excess of Solid Cancers After Prasugrel: The Food and Drug Administration Outlook. Am J Ther. 2016;23(1):e243–4.
Ohman, E. Magnus, and Matthew T. Roe. “Excess of Solid Cancers After Prasugrel: The Food and Drug Administration Outlook.” Am J Ther, vol. 23, no. 1, 2016, pp. e243–44. Pubmed, doi:10.1097/MJT.0b013e31824ea5f9.
Ohman EM, Roe MT. Excess of Solid Cancers After Prasugrel: The Food and Drug Administration Outlook. Am J Ther. 2016;23(1):e243–e244.
Published In
Am J Ther
DOI
EISSN
1536-3686
Publication Date
2016
Volume
23
Issue
1
Start / End Page
e243 / e244
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Prasugrel Hydrochloride
- Platelet Aggregation Inhibitors
- Neoplasms
- Humans
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services